Vaccines Archives - Infectious Disease Advisor

Influenza Vaccination Cuts Risk of Critical Illness in Children

By

January 21, 2022

During a season predominated by 2 vaccine-mismatched viruses, vaccination was estimated to reduce the risk of life-threatening influenza illness by 75%.

General Infectious Disease

FDA Grants Fast Track Status to Intranasal Pertussis Vaccine

By

Brian Park, PharmD

January 11, 2022

The designation is supported by data from 4 clinical trials evaluating BPZE1 in healthy adults.

COVID19

CDC Shortens Recommended COVID-19 Isolation, Quarantine Period

By

Brian Park, PharmD

January 5, 2022

The CDC has also updated the recommended quarantine period for individuals exposed to someone with COVID-19.

COVID19

NVX-CoV2373 Vaccine Protects Against COVID-19

January 4, 2022

The adjuvanted, recombinant spike protein nanoparticle vaccine, NVX-CoV2373, is effective for the prevention of COVID-19 in adults.

COVID19

Supplemental BLA Submitted for Pfizer-BioNTech COVID-19 Vaccine for 12- to 15-Year-Olds

By

Brian Park, PharmD

December 22, 2021

The application is supported by data from a randomized, placebo-controlled phase 3 trial which included 2228 participants 12 to 15 years of age enrolled in the United States.

Prevention

Update on the Safety and Efficacy of MMR/MMRV Vaccines in Pediatric Patients

By

Jessica Nye, PhD

December 21, 2021

Researchers conducted a study to assess the effectiveness, safety, and adverse effects associated with the measles-mumps-rubella and varicella vaccines in children aged 15 years and younger.

COVID19

Contraindication Added to Janssen COVID-19 Vaccine Fact Sheet

By

Diana Ernst, RPh

December 20, 2021

Cases of TTS have been reported in both males and females.

COVID19

British Study Shows Vaccines Weaken Against Omicron, but Boosters Help

December 17, 2021

The ability of two-dose COVID-19 vaccines to protect against symptomatic infection by the omicron variant falls significantly short, but a booster shot provides considerable protection.